Comparative Pharmacology
Head-to-head clinical analysis: PROBAMPACIN versus VEETIDS 500.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROBAMPACIN versus VEETIDS 500.
PROBAMPACIN vs VEETIDS '500'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PROBAMPACIN is a synthetic aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, causing misreading of mRNA and preventing translocation of peptidyl-tRNA from the A-site to the P-site.
VEETIDS '500' (cefuroxime axetil) is a second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby blocking transpeptidation and leading to cell lysis. It has activity against both gram-positive and gram-negative bacteria.
100 mg IV every 12 hours over 30 minutes.
1 tablet (500 mg) orally twice daily for 7 days.
None Documented
None Documented
4.5 hours (prolonged to 12-18 hours in severe renal impairment)
4-6 hours (prolonged in renal impairment; requires dose adjustment if CrCl <30 mL/min)
Renal: 70% unchanged; biliary/fecal: 20% as metabolites; 10% other
Renal: 60-80% unchanged; biliary/fecal: 15-25% as metabolites
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic